Despite modern advances in cancer diagnosis technology, the detection rate for invasive ovarian cancer is quite low, and the process is challenging, using a combination approach of transvaginal ultrasound and the serum cancer antigen-125 (CA-125) test. The gene discussed is MUC16; the disease is cancer.